9 Investments Driving Growth: Limitless Synergies Despite the challenges, the synergies between Israel and Japan remain strong. “Israel’s strengths in cybersecurity, food-tech, climate-tech, healthtech, industry 4.0, agri-tech, and AI align well with Japan’s needs in these sectors, especially in robotics, automotive, and healthcare, making them prime sectors for Israeli entrepreneurs to explore,” adds Arale Cohen, Co-Founder and Managing Partner of One Line Group. Akira at MH&M: “Japanese companies recognize Israel’s comparative strength in pure innovation and see such technology as a necessary driver for growth. They actively integrate innovative solutions of Israel startups into their existing platforms. The technology sector offers significant synergy, especially true in areas like fintech, climate/green tech, agritech, food tech, digital health, cybersecurity, and AI. Automotive or mobility are also critical areas for collaboration.” “Israel is widely regarded as a world leader in cybersecurity, with its startups and established firms developing cutting-edge technologies for intrusion detection, threat intelligence, and data protection,” agrees Masato. “For Japan, where cybersecurity has become a critical priority, particularly in sectors like finance, manufacturing, and public infrastructure, Israeli solutions offer an excellent fit. Japan’s digital transformation and the increasing adoption of IoT and AI technologies create vulnerabilities that Israeli companies can effectively address.” Japan’s aging population – opportunities for Israeli health-tech “Japan’s aging population presents a significant opportunity for Israeli healthtech companies to introduce cutting-edge solutions, such as AI-driven diagnostics, telemedicine platforms, and robotic-assisted healthcare devices. Israeli startups specializing in AI diagnostics, digital health platforms, and wearable devices are well-positioned to address these challenges. Israel’s advancements in AI align with Japan’s leadership in robotics, enabling joint development in areas such as medical robots and automated elder care systems. Partnerships between Japanese pharmaceutical firms and Israeli biotech companies to develop novel treatments. Collaborations in health-tech,
RkJQdWJsaXNoZXIy MjgzNzA=